Wockhardt shares surge 40% in 5 days on anticipation of antibiotic launch
Open Demat A/C Wockhardt antibiotic treats cancer patient in US: Milestone achievement for Zaynich (WCK 5222)
Open Demat A/C Wockhardt applies for Nafithromycin approval from the Drug Controller General of India to treat pneumonia
Open Demat A/C
Market expansion strategy: Wockhardt targeting a $1.5 billion opportunity in developed countries and $263 million in developing markets
Open Demat A/C With Our Subscription Plans
Open demat account in 5 minutes*
Open Demat A/C G-L92HWH8MZR